Bank Pictet & Cie (Europe)’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
NAM
CCP
PF
TRCT
Bank Pictet & Cie (Europe)'s SBIO Position: Q2 2021 in Review
Bank Pictet & Cie (Europe) sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2021, closing a stake of 4,400 shares — an estimated $221K sold.
Bank Pictet & Cie (Europe) first reported a position in SBIO in Q1 2021 and held it in 1 quarter. The position peaked at $221K in Q1 2021. 66 funds tracked by Wall St. Rank hold SBIO as of Q2 2021.
- Bank Pictet & Cie (Europe) reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2021 after selling out during the quarter.
- Bank Pictet & Cie (Europe) sold 4,400 ALPS Medical Breakthroughs ETF shares in Q2 2021, an estimated $221K.
- Bank Pictet & Cie (Europe) first reported a position in ALPS Medical Breakthroughs ETF in Q1 2021 and held it in 1 quarter.
- Bank Pictet & Cie (Europe)'s ALPS Medical Breakthroughs ETF position peaked at $221K in Q1 2021.
- 66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2021.
Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2021, filed 11 Aug 2021.